首页> 外文OA文献 >Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen

【2h】

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen

机译：西妥昔单抗联合铂类化学疗法治疗头颈部鳞状细胞癌：一项随机，双盲安全性研究，比较了使用EXTREME研究方案从两种生产工艺生产的西妥昔单抗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen [J] . Denis Soulières, Jose Luis Aguilar, Eric Chen, BMC Cancer . 2016,第1期

机译：西妥昔单抗联合铂类化疗治疗头颈部鳞状细胞癌：一项随机，双盲安全性研究，比较了使用EXTREME研究方案从两种生产工艺中生产的西妥昔单抗
2. 5501 ORAL Cetuximab plus platinum-based therapy first-line in recurrent and/or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Efficacy and safety results of a randomized phase III trial (EXTREME) [J] . J.B.Vermorken, R.Hitt, L.Geoffrois, European Journal of Cancer Supplements . 2007,第4期

机译：5501口服西妥昔单抗联合铂类疗法治疗头颈部复发和/或转移性（R / M）鳞状细胞癌（SCCHN）的一线研究：一项随机III期试验（EXTREME）的疗效和安全性结果
3. Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) [J] . Robert L Ferris, Ezra Cohen, Kelly Gash, Journal for ImmunoTherapy of Cancer . 2014,第S3期

机译：Active8：一项化疗，西妥昔单抗联合TLR8激动剂VTX-2337对头颈部复发或转移性鳞状细胞癌（SCCHN）患者的随机，双盲，安慰剂对照研究
4. Interstitial photodynamic therapy in combination with Cetuximab for recurrent head and neck squamous cell carcinoma [C] . Nestor Rigual, Ambujakshan Dildeep, Gal Shafirstein Conference on photonic therapeutics and diagnostics IX . 2013

机译：间质性光动力疗法联合西妥昔单抗治疗复发性头颈部鳞状细胞癌
5. Benzyl Isothiocyanate as an Adjuvant Chemotherapy Option for Head and Neck Squamous Cell Carcinoma. [D] . Wolf, Mary Allison. 2014

机译：异硫氰酸苄酯作为头颈鳞状细胞癌的辅助化疗选择。
6. Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen [O] . Denis Soulières, Jose Luis Aguilar, Eric Chen, 2016

机译：西妥昔单抗联合铂类化学疗法治疗头颈部鳞状细胞癌：一项随机双盲安全性研究比较了使用EXTREME研究方案从两种生产工艺生产的西妥昔单抗
7. Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: A randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen [O] . Soulieres Denis, Aguilar Jose Luis, Chen Eric, 2016

机译：西妥昔单抗联合铂类化疗治疗头颈部鳞状细胞癌：一项随机，双盲安全性研究，比较了使用EXTREME研究方案从两种生产工艺中生产的西妥昔单抗

Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a randomized, double-blind safety study comparing cetuximab produced from two manufacturing processes using the EXTREME study regimen

著录项

引文网络

相似文献

相关主题

期刊订阅